GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Amazon in Exploratory Talks With Mylan, Novartis About Pharma Entry November 30, 2017 Semler Scientific Reports Fourth Quarter And Annual 2016 Financial Results March 9, 2017 Celsion To Hold First Quarter 2017 Financial Results Conference Call On Friday, May 12, 2017 May 4, 2017
Celsion To Hold First Quarter 2017 Financial Results Conference Call On Friday, May 12, 2017 May 4, 2017
